Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | AMGN | VRTX | BMY | GILD |
| Company | Ra Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 47.99 | 318.69 | 471.06 | 55.88 | 88.31 |
| High | 48.01 | 321.70 | 475.73 | 55.90 | 89.57 |
| Low | 47.98 | 316.91 | 463.14 | 54.20 | 88.19 |
| Last | 48.00 | 319.22 | 471.12 | 54.32 | 89.51 |
| Change | -0.02 | -0.94 | -4.86 | -1.45 | +0.69 |
| % Change | -0.03% | -0.29% | -1.02% | -2.60% | +0.78% |
| Volume | 3,864,600 | 1,826,700 | 1,352,700 | 12,894,800 | 6,485,800 |
| 20-Day Average Volume | 1,869,975 | 1,679,710 | 1,035,860 | 8,762,979 | 5,116,895 |
| Previous Close | 48.01 | 320.16 | 475.98 | 55.77 | 88.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 319.66 | 475.65 | 52.96 | 87.00 |
| 20-Day Raw Stochastic | 99.68% | 46.33% | 45.57% | 61.55% | 95.87% |
| 20-Day Relative Strength | 56.47% | 47.71% | 48.30% | 59.45% | 68.08% |
| Weighted Alpha | +21.70 | +16.17 | +22.10 | +10.38 | +20.53 |
| Today's Opinion | 56% Buy | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 80% Buy | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | +0.71% since 10/25/24 | -1.38% since 10/25/24 | +4.62% since 10/25/24 | +0.57% since 10/25/24 |
| Low | 46.34 on 03/26/20 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 51.81 on 10/28/24 | 86.81 on 10/29/24 |
| High | 48.02 on 03/31/20 | 323.40 on 10/31/24 | 478.32 on 10/28/24 | 56.20 on 10/31/24 | 89.57 on 11/01/24 |
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | -0.34% since 10/01/24 | +0.29% since 10/01/24 | +2.68% since 10/01/24 | +6.64% since 10/01/24 |
| Low | 40.30 on 03/18/20 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 83.10 on 10/02/24 |
| High | 48.02 on 03/31/20 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 56.20 on 10/31/24 | 89.74 on 10/25/24 |
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | -4.86% since 08/01/24 | -6.85% since 08/01/24 | +12.77% since 08/01/24 | +17.02% since 08/01/24 |
| Low | 40.30 on 03/18/20 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 48.02 on 03/31/20 | 339.17 on 09/23/24 | 508.65 on 08/02/24 | 56.20 on 10/31/24 | 89.74 on 10/25/24 |
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | +15.09% since 05/01/24 | +17.15% since 05/01/24 | +22.87% since 05/01/24 | +36.64% since 05/01/24 |
| Low | 22.25 on 10/08/19 | 274.90 on 05/02/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 48.02 on 03/31/20 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.20 on 10/31/24 | 89.74 on 10/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 171,526,160 | 121,597,008 | 110,128,096 | 111,439,232 |
| Shares Outstanding, K | 47,329 | 537,329 | 258,102 | 2,027,395 | 1,244,992 |
| Annual Sales | 3,000,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -102,690,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 3,000,000 | 8,388,000,000 | 2,645,600,000 | 12,201,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -24,980,000 | 746,000,000 | -3,593,600,000 | 1,680,000,000 | 1,614,000,000 |
| 60-Month Beta | 1.04 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 05/14/20 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.66 | 0.00 | 47.67 | 18.90 |